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Abstract 350 words 
Skeletal muscle is increasingly considered as an endocrine organ secreting myokines and 
extracellular vesicles (exosomes and microvesicles), which can effect physiological changes 
with impact in different pathological conditions, including regenerative processes, aging and 
myopathies. Primary human myoblasts are an essential tool to study the muscle vesicle 
secretome. Since their differentiation in conditioned media does not induce any signs of cell 
death or cell stress, artefactual effects from those processes are unlikely. However, adult human 
primary myoblasts senesce in long-term tissue culture, so a major technical challenge is posed 
by the need to avoid artefactual effects resulting from pre-senescent changes. Since these cells 
should be studied within a strictly controlled pre-senescent division count (<21 divisions), and 
yields of myoblasts per muscle biopsy are low, it is difficult or impossible to amplify sufficiently 
large cell numbers (some 250 x 106 myoblasts) to obtain sufficient conditioned medium for the 
standard ultracentrifugation approach to exosome isolation. 
Thus an optimized strategy to extract and study secretory muscle vesicles is needed. In this 
study, conditions are optimized for the in vitro cultivation of human myoblasts, and the quality 
and yield of exosomes extracted using an ultracentrifugation protocol are compared with a 
modified polymer-based precipitation strategy combined with extra washing steps. Both vesicle 
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extraction methods successfully enriched exosomes, as vesicles were positive for CD63, CD82, 
CD81, floated at identical density (1.15-1.27 g.ml-1), and exhibited similar size and cup-shape 
using electron microscopy and NanoSight tracking. However, the modified polymer-based 
precipitation was a more efficient strategy to extract exosomes, allowing their extraction in 
sufficient quantities to explore their content or to isolate a specific subpopulation, while requiring 
>30 times fewer differentiated myoblasts than what is required for the ultracentrifugation 
method. In addition, exosomes could still be integrated into recipient cells such as human 
myotubes or iPSC-derived motor neurons. 
Modified polymer-based precipitation combined with extra washing steps optimizes exosome 
yield from a lower number of differentiated myoblasts and less conditioned medium, avoiding 
senescence and allowing the execution of multiple experiments without exhausting the 
proliferative capacity of the myoblasts.  
Key words: extracellular vesicle, muscle exosome extraction in vitro, muscle secretome  
 
INTRODUCTION:  
In addition to its classical role in locomotion, skeletal muscle is increasingly recognized to have 
a role in signalling, via its secretory functions. Interleukin-6 (IL-6) [1] and musculin [2] have been 
identified to originate and be secreted from skeletal muscle in vivo, and the secretomic profiles 
of muscle cells in vitro, such as C2C12 myotubes [3,4], human myotubes [5] and rat muscle 
explants [6], include growth factors (e.g. follistatin like protein 1, IGF2, TGF), cytokines, and 
inhibitors of collagenase (e.g. TIMP2). These studies suggest that skeletal muscle can be 
viewed as an endocrine organ. Secreted proteins - also named myokines [2] - may act in an 
autocrine/paracrine manner on muscle cells or other types of cell and contribute to muscle 
growth and regeneration, body-wide metabolism, and other functions [see [7] for review].  
In addition to proteins exiting the cell by classical secretory pathways, muscle cells also release 
protein-associated vesicles [5]. These extracellular vesicles (EVs) are widely studied in different 
physiological and pathological contexts, and are known to play a key role in tissue homeostasis 
[8], embryogenesis and development [9], cell survival [10], inflammatory and metabolic diseases 
[11,12], cancer metastasis [13]. EVs are broadly classified as exosomes, ectosomes or 
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apoptotic bodies. Exosomes (40-120nm) are formed from the endolysosomal pathway and are 
released into the extracellular space when multivesicular bodies containing intraluminal vesicles 
undergo exocytosis [14]. Ectosomes (100-1000nm) encompasses microvesicles, microparticles 
or shedding vesicles and are formed from the direct budding of the plasma membrane [15]. 
Finally, apoptotic bodies (500-2000nm) result from the outward bulge of the cell membrane due 
to cytoskeleton dysfunction and usually contain a part of the cytoplasm [16]. Human skeletal 
muscle cells are known to secrete two categories of veisicle, exosomes and microvesicles [5]. 
Both types of muscle cell vesicle can fuse and deliver functional proteins into target cells, as 
shown by the delivery of alkaline phosphatase through vesicles to human dermofibroblasts that 
do not have an endogenous activity for alkaline phosphatase [5]. Exosomes and microvesicles 
from other cell types have been described to play a role in intercellular communication, and to 
induce physiological changes in recipient cells, such as induction of cellular oncogenic 
transformation [17], or T-cell activation [18]. While the role of cytokines (e.g. [19–21])  and 
vesicles (e.g. [18,22]) originating from inflammatory cells is well documented, the role of their 
secretion by myoblasts or differentiating myotubes is relatively unexplored, particularly 
concerning regenerative processes in injury and ageing, and inflammatory and fibrotic 
processes in various muscle pathologies. Primary human myoblasts obtained from muscle 
biopsies are an invaluable in vitro tool for studying a pure human muscle secretome but this 
poses a technical challenge relating to the volume of conditioned media required per data point 
and their limited proliferative capacity [23]. Since primary human myoblasts should be studied 
within a strictly controlled pre-senescent division count (<21 divisions), and yields of myoblasts 
per muscle biopsy can be low, it can be difficult or impossible to amplify sufficiently large cell 
numbers (some 250x106 myoblasts) to obtain sufficient conditioned medium for certain 
approaches to exosome isolation. 
The isolation of exosomes from cell culture have been achieved by ultracentrifugation-based 
methods [24,25], size-based techniques [24,26,27], polymer-based precipitation [28] and 
immunoaffinity capture-based techniques [24]. Ultracentrifugation is considered the gold 
standard and is the most reported exosome isolation technique [29]. However, 
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ultracentrifugation has several shortcomings including the need for a large volume of biological 
fluid or conditioned cell culture media, long run-time, and limited reproducibility [30].  
In this study, we highlight the challenges surrounding the study of vesicles secreted by primary 
human muscle cells and we compare two strategies – (1) ultracentrifugation-based isolation and 
(2) a modified polymer-based precipitation approach – in terms of quality and yield of exosomes. 
We define an optimized protocol to extract exosomes from primary muscle cells, without 
exhausting the number of pre-senescent divisions, and thereby enabling a larger number of 
experiments to be carried out on a given cell line. 
MATERIALS AND METHODS: 
Primary cell extractions 
Six deltoid muscle biopsies were obtained from ALS patients (50.0 ± 6.5 years old) who attended 
the Motor Neuron Diseases Center (Pitié Salpétrière, Paris), and 17 muscle biopsies from 
healthy subjects (51.4 ± 18.2 years old) from the BTR (Bank of Tissues for Research, a partner 
in the EU network EuroBioBank) in accordance with European recommendations and French 
legislation. The protocol (NCT01984957) was approved by the local Ethical Committee. Written 
informed consent was obtained from all patients. All biopsies were isolated from deltoid muscle.  
Cell culture Proliferation and Differentiation 
Primary human myoblasts were extracted from fresh muscle biopsies as described previously 
[31]. Briefly, myoblasts were sorted using CD56 magnetic beads (Milteny®) and expanded in 
0.22µm filtered proliferating medium containing DMEM/M199 medium supplemented with 20% 
FBS, 25µg/ml Fetuin, 0.5ng/ml bFGF, 5ng/ml EGF, 5µg/ml insulin and incubated at 5%CO2, 
37 °C. The number of cell divisions was calculated using the formula below. The myogenicity of 
the culture was determined by counting the number of nuclei positive for desmin against the 
total number of nuclei using the primary antibody anti-desmin (D33, 1 :100, Dako). Secondary 
antibody was goat anti-mouse IgG1 AlexaFluor 594 (1:400, Invitrogen™), and counterstaining 
was performed with 1µg.ml-1 DAPI as described below. After CD56 MACS sorting, 91.78±8.32% 
of the cells were myogenic. 
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𝐷𝑖𝑣𝑖𝑠𝑖𝑜𝑛	𝑛𝑢𝑚𝑏𝑒𝑟 = log	(𝐶𝑒𝑙𝑙	𝑛𝑢𝑚𝑏𝑒𝑟	𝑎𝑡	𝑑𝑎𝑦	𝑛𝐶𝑒𝑙𝑙	𝑛𝑢𝑚𝑏𝑒𝑟	𝑝𝑙𝑎𝑡𝑒𝑑 )log 2  
For differentiation into myotubes, 7.5 x 106 myoblasts were plated in 225cm2 flask (Falcom™) 
and let adhere overnight. Seeded myoblasts were then washed six times with supplement free 
DMEM and differentiated in DMEM for 72 hours. Conditioned medium was then collected and 
used for exosome extraction. 
Beta-galactosidase staining 
The senescence level was assessed using a Senescence β-Galactosidase Staining Kit (Cell 
Signaling Technology®). 
Cell immunostaining 
The cells were fixed with 3.6% formaldehyde, permeabilised, blocked and stained as described 
previously [32]. Primary antibody anti-myosin heavy chain (MF20, 1:50, DSHB) and secondary 
antibody goat anti-mouse IgG2b AlexaFluor 594 (1:400, Invitrogen™) were used to determine 
the formation of myotubes. The slides were washed and counter-stained with 1µg.ml-1 DAPI for 
2 min and then rinsed twice with PBS before being mounted with ibidi mounting medium (ibidi®).  
Protein extraction from cells 
Myoblasts were scraped into 50 µl of chilled RIPA lysis buffer (Invitrogen™) supplemented with 
1x Halt™ protease inhibitor cocktail (Thermo Scientific™) and, incubated on ice for 10min. Cell 
lysates were then centrifuged at 14,000 g for 10min at 4 °C  and protein supernatants were 
collected and stored at -80ºC for downstream SDS-PAGE and immunoblotting. 
Condition culture media clearance  
At the time of collection, the conditioned medium is centrifuged at 200g for 10min. The 
subsequent supernatant was then centrifuged at 4,000g for 20min. The resulting supernatant 
was centrifuged for 70min at 4°C at 20,000g and then filtered through a 0.22µm filter. The 
cleared medium was then stored at -80°C prior to exosome extraction.  
Muscle exosome extraction using ultracentrifugation 
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Cleared media were centrifuged at 100,000g for 70min at 4°C following a method described 
previously [24]. The subsequent pellet was resuspended in PBS and washed three times by 
centrifugation at 100,000g for 70min at 4°C. The clean pellet was then resuspended in 100ul of 
PBS or in NuPAGE™ LDS sample buffer for Western blot experiments. 
Exosome Extraction using polymer precipitation  
Cleared culture media was mixed with the Total Exosome Isolation kit (LifeTechnologies™) at 
a 2:1 volume ratio and incubated at 4°C overnight. The mixture was then centrifuged at 10,000g 
for 60min at 4°C. The subsequent pellet was resuspended in 500 µl of PBS and washed three 
times using 100kDa Amicon® filter column. The exosomes were then resuspended in 100µl of 
PBS or in NuPAGE™ LDS sample buffer for Western blot experiments. 
Exosome Protein extraction  
Exosomes were lysed in 8M urea supplemented with 1x Halt™ Protease Inhibitor cocktail 
(Thermo Scientifc™) and 2% SDS. Samples were incubated at 40C for 15min, and exosome 
lysates were centrifuged at 14,000g for 10min at 40C. Supernatants containing soluble proteins 
were stored at -800C.  
SDS-PAGE and Western Blotting 
SDS-PAGE was performed as follows. For cell lysates, protein concentrations were measured 
at 562 nm using the bicinchoninic acid assay kit (Pierce™) and 20 µg of protein was mixed with 
4x NuPAGE™ LDS sample buffer. For exosome extracts, proteins were also mixed with 4x 
NuPAGE™ LDS sample buffer. For reducing conditions, samples were supplemented with 10x 
NuPAGE™ reducing agent. For immunoblotting of tetraspanins, samples were prepared 
similarly but for the omission of reducing agents. All samples were then denatured at 70 °C for 
10 min before being added to a 4-12 % polyacrylamide Bis-Tris gel (Life Technologies™) and 
electrophoresed at 200 v for 70 min in MOPS SDS Running buffer (LifeTechnologies™). 
Following electrophoresis, the gel was incubated in 20 % ethanol for 10 min and proteins were 
transferred onto polyvinylidene fluoride membrane using the iBlot™ 2 Dry Blotting system 
(LifeTechnologies™) according to manufacturer’s instructions.  
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Immunoblotting was performed using the iBind™ Flex western system following the 
manufacturer’s instructions (Life Technologies™). PVDF membrane was probed with primary 
antibodies forPARP-1 (9542, Cell Signaling, rabbit IgG, 1:1000), or CD63 TS63 (10628D, Life 
Technologies™, mouse, 2µg/ml), or CD81 (MA5-13548, Life Technologies™, mouse IgG, 
1:100, v:v dilution), Flotillin (PA5-18053, Life Technologies™, 0.3µg/ml) or HSPA8 (MABE1120, 
Millipore, mouse IgG, 1:1000 ) or Alix (SC-53540, Santa Cruz, 1:1000) and Goat anti-mouse or 
Goat anti-rabbit secondaries conjugated with HRP (LifeTechnologies™, 1:400, and 1:10,000 
respectively). The membrane was then incubated with Amersham ECL Prime Western Blotting 
Detection Reagent for 5 minutes at room temperature and images were subsequently acquired 
using the UVP ChemiDoc-It™2 Imager and UVP software.  
Electron microscopy and immunogold  
Extracted and further whole-mounted vesicles were processed as described in [24]. 
Observations were made using a CM120 transmission electron microscope (Philips, Eindhoven, 
The Netherlands) at 80 kV and images recorded with a Morada digital camera (Olympus Soft 
Imaging Solutions GmbH, Münster, Germany). 
Determination of the exosome density 
Exosomes extracted from cell culture medium using either ultracentrifugation or polymer-based 
precipitation were resuspended in 100µl of PBS and loaded on the top of the sucrose gradient 
as previously described [5,32]. Samples were then centrifuged at 100,000g for 17 hr at 40C. 
Twelve fractions were sequentially collected, diluted in 12 ml PBS and centrifuged at 100,000g 
for 70min at 40C. Each pellet was then resuspended in non-reducing NuPAGE™ LDS sample 
buffer and used for western blot analyses as described above. The density gradient of each 
fraction was determined using the method described by [33] by measuring the absorbance at 
244 nm:  
Density (g.cm-3) = !"#$%"&'()	&+	,--	'.	/	0.2,340.25--  
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Nanoparticle tracking analysis (NTA)  
Exosome pellets were resuspended in 100µl of filtered PBS. The exosome suspension was then 
diluted 10x in PBS. Size and distribution of exosomes secreted by primary muscle cells were 
evaluated by a NanoSight LM10 instrument (NanoSight) equipped with NTA analytic software 
(version 2.3 build 2.3.5.0033.7-Beta7). Three videos of 30 s were as previously described 
[34,35] at temperature set to 22.5C. The minimum particle size, track length and blur were 
set to “automatic”.  
Proteomic analysis 
- The exosome pellets were re-suspended in 25μl 8M Urea, 50 mM ammonium 
bicarbonate, pH 8.5, and reduced with DTT for 1 h at 4˚C. Protein concentrations were 
then quantified using Pierce BCA Protein Assay kit (ThermoFisher®). Exosomal proteins 
were kept at -80°C.  
- Proteome profile determined by Mass spectrometry - 20 µg of exosome protein were 
trypsin digested using a SmartDigest column (Thermo) for 2h at 70°C and centrifugated 
at 1400rpm.  Peptides were then fractionated into 8 fractions using a high pH reverse 
phase spin column (Thermo). Fractioned peptides were vacuum dried, resuspended and 
analyzed by data-dependent mass spectrometry on a Q Exactive HF (Thermo) with the 
following parameters: Positive Polarity, m/z 400-2000 MS Resolution 70,000, AGC 3e6, 
100ms IT, MS/MS Resolution 17,500, AGC 5e5, 50ms IT, Isolation width 3 m/z, and NCE 
30, cycle count 15. 
- Database Search and Quantification - The MS raw data sets were searched for protein 
identification for semi tryptic peptides against the Uniprot human database for semi 
tryptic peptides including common contaminants, using MaxQuant software (version 
1.6.2.1) (https://wSww.biochem.mpg.de/5111795/maxquant). We used default 
parameters for the searches: mass tolerances were set at +/- 20 ppm for first peptide 
search and +/- 4.5 ppm for main peptide search, maximum two missed cleavage; and 
the peptide and resulting protein assignments were filtered based on a 1% protein false 
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discovery rate (thus 99% confidence level). 1254 proteins were detected in at least 1 
sample. The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE partner repository with the dataset 
identifier PXD015736. 
- To test for overlap with known exosome proteins from previous studies, all proteins 
detected in at least 1 proteomic sample were entered into the Funrich tool for vesicle 
functional analysis [36–39], and a Venn diagram generated against the subset of the 
Vesiclepedia database comprising previously observed exosomal proteins detected by 
mass spectrometry in human samples. 
 
mRNA extraction from polymer precipitated exosomes 
Exosomes were first dissolved in 900 µl TRIzol® (Invitrogen™), then 200 µl of chloroform was 
added. After 5min of incubation at RT, samples were centrifuged at 12,000 g for 15min at 4°C. 
The aqueous phase containing the RNA was transferred into a collection and mixed with 75% 
ethanol (1:1, v:v). mRNA was then purified using PureLink® RNA Mini Kit (LifeTechologies™) 
following manufacturer’s instructions. RNA eluates were stored at -80°C until use. 
Concentration of each RNA sample was determined by NanoDrop® spectrophotometer ND-
1000 (NanoDrop Technologies, Wilmington, DE). The quality of RNA samples was assessed with 
the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA).  
Immunoprecipitation of muscle exosome subpopulation 
Polymer precipitated exosomes were immunoprecipitated using anti-CD63 magnetic beads 
(Invitrogen™) overnight according to manufacturer’s instructions. Magnetically captured beads 
were then washed 3 times in PBS and CD63 positive exosomes were eluted in 4x NuPAGE™ LDS 
sample buffer. Samples were then used for western blot analyses as described above. 
Exosome functionality assessment  
 10 
The exosomes were labelled with the PKH26 kit (Sigma-Aldrich®). Briefly, 100 µl of Diluent C 
was added to the exosome suspension and labelled with 100 µl of 4 µM PKH26 solution. After 
5 min of incubation, samples were washed 3 times in PBS using a 100kDa Amicon® filter column 
and centrifuged at 12,000xg at 4°C for 15 min. Muscle exosomes extracted from 3,000 
differentiated myoblasts were either added to 3,000 human iPSC derived motor neurons or to 
3,000 differentiated human myoblasts. Human iPSC derived motor neurons were differentiated 
from human neuron progenitors as described in [40]. Uptake of muscle exosomes by recipient 
cells was observed after 24h incubation in living cells using an Olympus IX170 inverted 
microscope, with a 40x/0.60 Ph2 objective equipped with an AxiocamMR camera. 
Statistical analysis 
All values are presented as means ± SD. ANOVA 1 Factor followed by Tukey post-hoc test was 
used to compare differences between the different cell densities conditions. Differences were 
considered to be statistically different at P < 0.05. 
 
Results and discussion 
Determination of the window of cell divisions suitable to study the muscle secretome in 
non-senescent stages 
Previously published studies on muscle cells using the ultracentrifugation method  [5,32] showed 
that 250x106 cells were needed in order to have enough material for 1 single data point for 
proteomic and transcriptomic analysis. However, primary muscle cells can only execute a limited 
number of divisions, ~30-40 divisions with several outliers as low as 22 divisions (Fig. 1a-b, 
[31]), before they stop dividing and become senescent. The maximum number of divisions is 
not age-dependent, which is consistent with our previous study showing that the myoblasts 
extracted from subjects have the same proliferative capacity as myoblasts extracted from young 
adults [41] (Fig. 1b). Senescent cells can secrete factors including exosomes that can impact 
surrounding cells as observed with senescent endothelial cells [42], cerobroendothelial cells 
[43], or fibroblasts [44]. In order to avoid potential artefacts arising from cells that are nearing, 
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or have reached senescence, we suggest that myoblasts under 21 divisions should be used to 
study the muscle secretome (Fig. 1), and we therefore sampled cells within this window for all 
subsequent experiments. 
 
Figure 1: Maximum number of divisions reached by primary human muscle cells, and the 
number of divisions required to obtained sufficient cell numbers: a- Distribution of the 
maximum number of divisions that human muscle cells can execute. Each point represents one 
sample. Based on this number, a safe window to analyze fully active and proliferative muscle 
cells is under 21 divisions. Light blue: age 20-30, dark blue: age 30-40, grey: 40-50, black: 50-
75 years old. b- Absence of correlation between age and the maximum number of divisions. c-
Table showing the number of primary muscle cells obtained at different phases of cell culture. 
Typically, 470,000 CD56+ve muscle cells can be purified from a muscle biopsy culture after ~10 
divisions (first row, light green). The number of cells after each division, and the number of 
divisions, are given by row. Pink indicates the pre-senescence stage (based on the data in a) 
when cells may start to slow down their capacity to proliferate and then senesce (and rate of 
division drops from an average of 0.58 to 0.25). Importantly, for some subjects, the cells will not 
reach 30 divisions, as shown in plot 1a. Typical measurements of the number of days of 
expansion and of the average number of divisions per day are given on the right side of the 
table. d- Myoblasts under 21 divisions were negative for beta-galactosidase. Top right panel: 
positive control of senescent cells positive for beta-galactosidase. Scale bar = 100µm. e- No 
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cleaved PARP-1 was observed by Western blot, suggesting that myoblasts under 21 divisions 
do not show any sign of necrosis nor apoptosis.  
Optimization of the muscle cell culture conditions 
Muscle exosomes were extracted from myoblasts that had undergone between 16-20 divisions, 
seeded at a density of 33,400 cells.cm-2, and that were differentiated into myotubes for three 
days. Ninety five percent of the myoblasts were differentiated into myotubes in DMEM after three 
days (Fig.2a-c), covering over ~ 80% of the petri dish (Fig. 2d,e). Differentiated myoblasts were 
negative for Beta-galactosidase (Fig. 2d), confirming that they were not in a senescent state. 
Neither necrosis nor apoptosis were observed as PARP-1B was not cleaved (Fig. 2e). These 
data suggest that human muscle myoblasts which have made less than 20 divisions can 
differentiate efficiently into myotubes, are not senescent, and are therefore suitable for the study 
of the myotube secretome. 
 
Figure 2: Myoblasts at under 20 divisions differentiate efficiently and are not senescent. 
A total of 12 separate primary cell lines were cultured to under 21 divisions. a- Dot-plot showing 
the percentage of primary human myoblasts fused into myotubes for 12 separate cell cultures, 
with an average fusion index calculated as 95.14% ± 4.28. b- Representative images of 
myotubes positive for myosin heavy chain (in red), a marker of differentiation. Scale bar = 
100µm. c- Over 80% of the flask is covered and no obvious signs of cell death are observed. 
Scale bar = 100µm. 
Optimization of muscle exosome extraction 
Myoblasts were seeded at 7.5x106 cells per 225 cm2 flask. Due to the large volume of medium 
(250 ml per sample) required for ultracentrifugation, a total of 14 flasks, thus 100 million 
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differentiated myoblasts, were cultured per data-point and per experiment to compare the 
efficacy of the ultracentrifugation and polymer-based precipitation protocols. Myotubes were 
maintained in conditioned media for 3 days. After pre-clearing the media, as described in the 
materials and methods and as shown in Fig. 3, exosomes were extracted using either the 
ultracentrifugation strategy or polymer-based precipitation. Previous publications showed lower 
exosomal protein detection (e.g. CD63) by Western blot using the polymer-based precipitation 
compared to ultracentrifugation, despite observing a greater number of vesicles by NanoSight 
using polymer-based precipitation [28,45]. Based on these publications, we suspected that the 
polymer matrix was hiding epitopes. After rinsing the exosome extracts 3 times with PBS in 100 
kDa Amicon® filter columns, the accessibility of antibodies to epitopes was rescued (Fig. 3).  
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Figure 3: Schema summarizing the protocols used to extract muscle exosomes from 
primary human myotube culture medium, using either the ultracentrifugation or the 
modified polymer-precipitation strategy. For a single data point, 14 flasks of 225cm2 are 
plated with 7.5x106 myoblasts. After 24h, once the myoblasts have attached to the flask, they 
are rinsed 6 times in DMEM and then differentiated into myotubes by cultivating them in DMEM. 
After 72hr, the conditioned medium is collected for muscle exosome extraction. After removing 
dead cells (200g, 10 min, RT), cell debris (4,000g, 20 min, 4°C) and ectosomes (20,000g, 70 
min at 4°C, and filtered at 0.22µm), the cleared media is subjected to exosome extraction either 
by the ultracentrifugation protocol or by a modified polymer-precipitation protocol. 
Ultracentrifugation is at 100,000g (70 min, 4°C), which is followed by washing the pellets three 
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times with PBS (100,000g, 70 min, 4°C). The subsequent pellet is then either resuspended in 
100 µl of PBS or in NuPAGE™ LDS sample buffer for western blot. For the modified polymer-
precipitation protocol, the polymer is added at half the volume of the pre-cleared media, and 
incubated overnight at 4°C. The mix is then centrifuged at 10,000g for 70 min at 4°C. The 
subsequent pellet is then washed 3 times in PBS using a 100 kDa Amicon® filter column. 
Western blot shows the rescue of the epitope CD63 after 3 washes in PBS. 
The ultracentrifugation-based and modified polymer-based precipitation approaches 
both extract exosomes from conditioned cultured media of primary human myotubes, 
but the polymer-based approach is more efficient  
Exosomes secreted by 100x106 differentiated myoblasts and extracted using either 
ultracentrifugation or polymer-based precipitation show the same cup-shape structure by 
electron microscopy (Fig. 4a) and are positive for CD63, CD82 (Fig. 4 b,c) and CD81 (Fig.4c), 
and float at the same density (Fig.4c). Similar sized vesicles were observed by electron 
microscopy and by NanoSight analysis (Fig.4d). Importantly, the ultracentrifugation strategy was 
far less efficient than the polymer precipitation to extract exosomes as shown in Fig. 4c and d. 
A proteomic analysis revealed that the protein profile of the muscle vesicles extracted using the 
modified polymer-based precipitation is enriched in proteins known to be present in exosomes 
(Fig.4d) as given by Exocarta  [36–39].  
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Figure 4: Validation of exosome extraction strategy. For each experiment, exosomes were 
extracted from culture medium of 100x106 myoblasts differentiated into myotubes for 3 days 
using either the ultracentrifugation or the polymer precipitation. Culture medium was non-
supplemented DMEM (without serum). a-. Cup-shaped vesicles were observed by electron 
microscopy with both extraction protocols. bar = 100 nm. b- Both extractions show vesicles that 
are positive for CD63 and CD82 by electron microscopy. bar = 100 nm. c- Exosome extracts 
were loaded on iodixanol gradients as described in material and methods. Western blot results 
are shown for CD63 and CD81 in twelve fractions for the iodixanol gradient. Top panel: 
exosomes extracted by ultracentrifugation. Bottom panel: exosomes extracted by polymer-
based precipitation. Exosomes were detected at a density of 1.15-1.27 g.ml-1. d- Nanosight 
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analyses show similar sized vesicles using both strategies, from 100-200nm, with a greater 
number of particles being detected when using the polymer extraction. E- Proteomic analysis of 
muscle exosomes. Venn diagram showing the overlap between muscle exosomes and proteins 
known to be detected by mass spectrometry in exosomes (Vesiclepedia, Exocarta database 
[36–39]). 
Working with >30 times fewer myoblasts, the modified polymer precipitation strategy still 
efficiently extracts vesicles that can be used for follow up experiments.  
Previous publications suggested that the cell density may affect exosome secretion [46]. We 
thus tested different densities of differentiated myoblasts per cm2 and observed that the optimal 
conditions were 33,400 cells.cm-2 (Fig. 5a), thus 7.5 x 106 myoblasts for a 225 cm2 flask. 
Exosomes secreted by muscle cells were positive for CD63, CD81, Flotillin, HSPA8 and Alix 
(Fig. 5b). Exosomes extracted from 7.5x106 differentiated myoblasts could be used to explore 
exosome mRNA content (Fig. 5c), and could be used to isolate a specific subpopulation of 
exosomes such as CD63-positive vesicles (Fig. 5d). In addition, polymer precipitated exosomes 
can be stained with PKH26 and applied to recipient cells such as myotubes or iPSC-derived 
motor neurons (Fig. 5e). 
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Figure 5: Polymer-based precipitation efficiently extracts functional exosomes from 
7.5x106 cells. a- SDS-page protein quantification showing that the greatest efficiency in terms 
of exosomal protein per cell plated was obtained when exosomes were extracted from 
differentiated myoblasts at a density of 33,400 cells.cm-2. Differentiated myoblasts were plated 
at 14,147 (lane 1), 33,400 (lane 2) or 106,100 (lane 3) cells per cm2. Right panel: representative 
SDS-page stained with Coomassie. Left panel: protein concentration measurements in secreted 
exosomes from cells plated at different density. *, ***, P<0.05 and P<0.001, significantly different 
from 33,400 and 106,100 cells.cm2. (n=4, 3, 4 per condition) b- Muscle exosomes were positive 
for CD63, CD81, Flotillin, HSPA8, and Alix. c- mRNA was detectable with a clean profile from 
polymer-precipitated exosomes of 7.5x106 differentiated myoblasts. No 18s and 28s RNA were 
detected, indicating that there were no RNA contaminants from dead cells. Inset panel: 
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Representative electrophoresis obtain with Agilent 2100 Bioanalyzer for myotubes and exosome 
RNA extract. d- Western blot showing that polymer precipitated exosomes from 7.5x106 
differentiated myoblasts can be used to pull down a specific subpopulation such as CD63 
positive exosomes (+/-CD63 = with/without anti-CD63 antibody). e- Polymer precipitated 
exosomes (pre-stained with PKH26 following extraction; red channel) were capable of 
integrating into myotubes or into iPSC motor neuron cells.  
 
Conclusion 
Although emphasis has been given to the role of the muscle tissue environment in regeneration 
(e.g. in parabiosis experiments [47,48]), very little is known about the secretome of human 
muscle cells. The role of muscle as a secretory endocrine organ has been recently proposed 
and a number of studies have characterized the secretory profiles of muscle cells [5,7,32,49,50], 
but the role of muscle vesicles is an underexplored field, as is the putative cross-talk between 
different cell types. Exploring the content and function of vesicles secreted by purified human 
myoblasts will improve our understanding of how muscle communicates with its environment in 
different physiological (e.g. ageing) and pathological contexts (e.g. neuromuscular disorders, 
cachexia associated with cancer, etc) [51–54]. It may also provide new insights regarding the 
pathological mechanisms underlying such conditions and may help in the identification of novel 
biomarkers and novel therapeutic targets for diseases. 
Only a small number of human muscle cells can be obtained from muscle biopsies and these 
cells have a very limited capacity to divide. These caveats, along with the fact that muscle cells 
do not secrete large quantities of vesicles – consistent with muscle accounting for up to 50% of 
body mass - reinforce the importance of identifying strategies that allow for the most efficient 
extraction of muscle vesicles from a small quantity of starting material. 
Large amounts of starting material are required when using the ultracentrifugation-based 
technique [55], especially when there is an intention to perform downstream OMICS studies 
(e.g. proteomic, transcriptomic, metabolomic analyses; 250x106 muscle cells for one replicate 
[5]). Several commercial kits have been developed to improve isolation efficacy and speed. The 
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purity of vesicles isolated using these kits is often questioned in comparison to the 
ultracentrifugation methodology, especially when extracting from serum/plasma [56,57], but also 
in the in vitro context [58,59]. However, it is important to note that, whilst these studies do adhere 
strictly to the manufacturers’ instructions for usage of the kits, they often fail to carry out identical 
sample preparations prior to the comparison - for example, carrying out centrifugations and/or 
filtration steps to remove microvesicles and other contaminants before ultracentrifugation but 
neglecting to do so before using the kits. This, together with the epitope hiding property of the 
polymer that is discussed below in the context of additional rinsing steps, may largely account 
for differences in observed contamination rates. 
In the present study, muscle exosomes are extracted from differentiated human myoblasts that 
have been cultured in non-supplemented DMEM. This ensures that exosome preparations 
isolated using this method are fully depleted of any potential contaminants from culture medium 
additives such as fetal bovine serum. Furthermore, differentiated myoblasts cultured under 
these conditions undergo neither necroptosis nor apoptosis (current paper, [60]). When 
collecting the conditioned media, differential centrifugation steps and a filtration step are 
included to remove potential cell debris, apoptotic vesicles, and microvesicles. All of these 
precautions are carried out prior to the addition of the polymer solution, thus eliminating most, if 
not all potential contaminants and ensuring a highly purified isolation process, and we 
recommend that such steps are included no matter which subsequent exosome isolation method 
is used.  
The absence of medium supplementation, and the lack of necroptosis and apoptosis mean that 
the culture medium of differentiated human muscle cells is a non-complex sample, and is 
therefore well-suited to the protocol described here, as opposed to serum which includes many 
different types of vesicle and a relatively complex molecular milieu, thereby making it difficult to 
isolate exosomes by size and density alone, and requiring additional approaches such as 
exosome pull-down to maximise purity [61,62], but leading to the analysis of a specific circulating 
exosome subpopulation. 
Looking at the literature, we noticed that the polymer kit consistently led to a greater number of 
vesicles detected by NanoSight [56,59,63], and yet led to a reduced detection of exosomal 
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markers by Western blot [28,45,56,59,63,64]. Interestingly, Rider et al, while optimizing a 
polymer to extract extracellular vesicles, showed that rinsing of exosomes that had been 
precipitated using the polymer resulted in an increase in exosome markers detected by Western 
blot [28]. Based on that study, we decided use 100 kDa Amicon® filter columns to add extra 
washes after precipitating the vesicles from pre-cleared media. These additional steps removed 
the surplus of polymer [65], thereby rescuing the detection of exosomal markers (Fig. 3), and 
likely have the additional advantage of removing any cytokines [58] secreted by muscle cells. 
These extra rinsing step may also improve the functionality of the exosome-like vesicles, for 
experiments involving the incorporation of vesicles into recipient cells (Fig. 5e). 
Pre-clearing the culture medium followed by polymer precipitation and three PBS washes allows 
the extraction of exosome-like vesicles whilst using 33 times less starting material than what is 
needed when the ultracentrifugation protocol is used, and the quality and functionality of 
extracted exosomes is retained. The option of being able to carry out proteomic and functional 
analyses on exosomes whilst requiring much fewer cell numbers as a starting point is a critically 
important asset especially when dealing with primary cell cultures that quickly senesce [66,67]. 
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